Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies
- PMID: 33561611
- DOI: 10.1016/j.oraloncology.2020.105177
Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies
Abstract
In head and neck cancer (HNC), some subsites are associated with human papillomavirus (HPV) infection, whereas others are unrelated. Although studies have demonstrated the heterogeneity of HPV prevalence worldwide, its impacts on incidence trends in HNC are unknown. This systematic review examined the incidence trends for HPV-related HNC subsites, exploring patterns by geographic region, age group, sex, and race/ethnicity. We searched for publications on PubMed, Embase, and Scopus. Eligible articles included population-based studies that analyzed incidence trends for subsites classified as a proxy for HPV infection in HNC (hereafter referred to as HPV-related subsites). We retrieved 3,948 non-duplicate records, of which 31 were eligible articles, representing 18 countries and spanning almost fifty years. Overall, the incidence of HPV-related HNC subsites rose, while most of the HPV-unrelated subsites declined or remained stable. For HPV-related HNC subsites, incidence trends increased regardless of age group, highlighting a distinct global pattern between sexes. Also, similar peaks in increased risk were observed in recent cohorts from both Australia and the United States. There is a dramatic shift in the global trends of HNCs, characterized by the emerging burden in HNC for HPV-related subsites.
Keywords: Epidemiology; Mouth neoplasms; Oropharyngeal neoplasms; Papillomavirus infections; Trends.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.Int J Cancer. 2015 Jul 15;137(2):395-408. doi: 10.1002/ijc.29330. Epub 2014 Nov 24. Int J Cancer. 2015. PMID: 25395239
-
Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.PLoS One. 2012;7(3):e32657. doi: 10.1371/journal.pone.0032657. Epub 2012 Mar 20. PLoS One. 2012. PMID: 22448226 Free PMC article.
-
Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.Cancer. 2019 Jan 15;125(2):249-260. doi: 10.1002/cncr.31800. Epub 2018 Nov 16. Cancer. 2019. PMID: 30444527
-
Epidemiology of head and neck cancer.Surg Oncol Clin N Am. 2015 Jul;24(3):379-96. doi: 10.1016/j.soc.2015.03.001. Epub 2015 Apr 9. Surg Oncol Clin N Am. 2015. PMID: 25979389 Review.
-
[Infection of human papillomavirus and head and neck cancer].Zhonghua Zhong Liu Za Zhi. 2023 Jan 23;45(1):39-43. doi: 10.3760/cma.j.cn112152-20211130-00884. Zhonghua Zhong Liu Za Zhi. 2023. PMID: 36709118 Review. Chinese.
Cited by
-
Factors Associated with Attitudes towards Preventing Head and Neck Cancer through HPV Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2021.Vaccines (Basel). 2022 Apr 18;10(4):632. doi: 10.3390/vaccines10040632. Vaccines (Basel). 2022. PMID: 35455381 Free PMC article.
-
A Tumor-Infiltration CD8+ T Cell-Based Gene Signature for Facilitating the Prognosis and Estimation of Immunization Responses in HPV+ Head and Neck Squamous Cell Cancer.Front Oncol. 2021 Sep 28;11:749398. doi: 10.3389/fonc.2021.749398. eCollection 2021. Front Oncol. 2021. PMID: 34650931 Free PMC article.
-
Tumor Subtype Classification Tool for HPV-associated Head and Neck Cancers.bioRxiv [Preprint]. 2024 Jul 10:2024.07.05.601906. doi: 10.1101/2024.07.05.601906. bioRxiv. 2024. PMID: 39026719 Free PMC article. Preprint.
-
Advanced Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Unmet Need and Emerging Therapies.Mol Cancer Ther. 2024 Dec 3;23(12):1717-1730. doi: 10.1158/1535-7163.MCT-24-0281. Mol Cancer Ther. 2024. PMID: 39301607 Free PMC article. Review.
-
A clinician's dilemma: what should be communicated to women with oncogenic genital HPV and their partners regarding the risk of oral viral transmission?BMC Womens Health. 2022 Sep 17;22(1):379. doi: 10.1186/s12905-022-01965-x. BMC Womens Health. 2022. PMID: 36115987 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical